EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Prognostic Value of Systemic Inflammation Markers (NLR and Haemoglobin) in Non-Small Cell Lung Cancer: Survival Analysis from a Real-World Single-Centre Cohort Study

Carina Maria Golban iD, Lavinia Davidescu, Alexandru Alexandru iD, Silviu Vlad iD, Alina Gabriela Negru iD, Sorin Saftescu iD, Petrescu Codruta Ileana, Catalin Prodan Barbulescu iD, Serban Mircea Negru

Medicina · 28.02.2026 · 62 (3) · 467

DOI: 10.3390/medicina62030467 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Medicina, online erschienen am 28.02.2026. Verfasst von Carina Maria Golban und 8 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Hemoglobins, Inflammation, Lung Neoplasms. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Victor Babeș” University of Medicine and Pharmacy, Timișoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: In real-world NSCLC management, prognostic assessment extends beyond tumour staging and molecular profiling, which represent a partial timeframe of disease biology. Routinely collected inflammatory and haematological markers may better reflect the dynamic host–tumour interactions during treatment. This study assessed the prognostic significance of baseline and longitudinal neutrophil-to-lymphocyte ratio (NLR) and haemoglobin levels on survival outcomes in a real-world NSCLC cohort. Materials and Methods: We conducted a retrospective observational cohort study of 615 patients with histologically confirmed NSCLC diagnosed between 1 May 2022 and 30 April 2024 at a tertiary referral centre in western Romania. Survival outcomes, including progression-free and overall survival, were analysed through Kaplan–Meier curves, complemented by 12-month restricted mean survival time estimates. High NLR was defined as ≥3 and low haemoglobin as

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungHemoglobinsInflammationLung NeoplasmsAgedFemaleHumansMaleMiddle AgedBiomarkersCohort StudiesKaplan-Meier EstimateLymphocytesNeutrophilsPrognosisRetrospective StudiesRomaniaSurvival Analysis

Stichwörter der Autor:innen

NSCLClung cancerneutrophil-to-lymphocytenon-small cell lung cancer

Substanzen

BiomarkersHemoglobins

Autor:innen und Institutionen

  • Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
  • Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  • Department of Surgical Specialties, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  • Department of Cardiology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
  • Department of Oncology, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Department of Anatomy and Embryology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

ORCID-Profile: Carina Maria Golban, Alexandru Alexandru, Silviu Vlad, Alina Gabriela Negru, Sorin Saftescu, Catalin Prodan Barbulescu

Förderung

  • “Victor Babeș” University of Medicine and Pharmacy, Timișoara

Zitieren

APA

Golban, C. M., Davidescu, L., Alexandru, A., Vlad, S., Negru, A. G., Saftescu, S., Ileana, P. C., Barbulescu, C. P., & Negru, S. M. (2026). Prognostic Value of Systemic Inflammation Markers (NLR and Haemoglobin) in Non-Small Cell Lung Cancer: Survival Analysis from a Real-World Single-Centre Cohort Study. Medicina, 62(3), 467. https://doi.org/10.3390/medicina62030467

Vancouver

Golban CM, Davidescu L, Alexandru A, Vlad S, Negru AG, Saftescu S, et al. Prognostic Value of Systemic Inflammation Markers (NLR and Haemoglobin) in Non-Small Cell Lung Cancer: Survival Analysis from a Real-World Single-Centre Cohort Study. Medicina. 2026;62(3):467. doi:10.3390/medicina62030467

BibTeX
@article{Golban2026,
  author = {Golban, Carina Maria and Davidescu, Lavinia and Alexandru, Alexandru and Vlad, Silviu and Negru, Alina Gabriela and Saftescu, Sorin and Ileana, Petrescu Codruta and Barbulescu, Catalin Prodan and Negru, Serban Mircea},
  title = {Prognostic Value of Systemic Inflammation Markers (NLR and Haemoglobin) in Non-Small Cell Lung Cancer: Survival Analysis from a Real-World Single-Centre Cohort Study},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {3},
  pages = {467},
  doi = {10.3390/medicina62030467}
}
Kostenlos starten →